Sridhar Shilpa, Akoghlanian Shoghik, Krivchenia Katelyn
The Ohio State University, Columbus, Ohio, USA.
Pulmonary, Critical Care, and Sleep Medicine, The Ohio State University, Columbus, Ohio, USA.
Pediatr Pulmonol. 2025 Jan;60(1):e27311. doi: 10.1002/ppul.27311. Epub 2024 Nov 6.
Pediatric granulomatosis with polyangiitis (GPA) is associated with several pulmonary manifestations. This study aims to describe these manifestations at time of diagnosis and longitudinally at a tertiary-care pediatric hospital.
We performed a retrospective chart review of patients with GPA treated at our facility between 1 January 2010 through 31 December 2021. We collected baseline demographics, reported symptoms, imaging findings, pulmonary function tests (PFTs), and laboratory data at time of diagnosis. Data were collected using 6-month observation intervals to follow recurrence of respiratory manifestations, testing during recurrence, and resultant treatment modifications.
Of 13 patients treated for GPA during the study period, 12 developed respiratory tract involvement. A total of 87 6-month observation periods were analyzed. At time of diagnosis, 83% (10/12) of subjects reported respiratory symptoms, 92% (11/12) had abnormal chest computed tomography (CT) imaging, and 42% (5/12) had abnormal PFTs. Fewer than half of the patients were seen by pulmonology within 6 months of diagnosis. Eight subjects (75%) had respiratory manifestations during subsequent observation periods. Chest CT or PFTs were obtained in 23/44 (52%) of observations periods with respiratory symptoms, with pulmonary consultation in only 9/44 (20%).
This is the first US study to describe respiratory manifestations in pediatric GPA patients longitudinally, finding they are common and frequently recurrent. Our cohort had almost universally abnormal imaging at diagnosis regardless of respiratory symptoms. Early collaboration with pediatric pulmonology in the care of GPA patients may allow rheumatology teams to efficiently evaluate recurrent symptoms and address concomitant lung disease.
儿童肉芽肿性多血管炎(GPA)与多种肺部表现相关。本研究旨在描述在一家三级医疗儿科医院诊断时及纵向观察这些表现。
我们对2010年1月1日至2021年12月31日在我院接受治疗的GPA患者进行了回顾性病历审查。我们收集了诊断时的基线人口统计学资料、报告的症状、影像学检查结果、肺功能测试(PFT)和实验室数据。以6个月的观察间隔收集数据,以跟踪呼吸道表现的复发情况、复发时的检查以及由此导致的治疗调整。
在研究期间接受GPA治疗的13例患者中,12例出现呼吸道受累。共分析了87个6个月的观察期。诊断时,83%(10/12)的受试者报告有呼吸道症状,92%(11/12)的胸部计算机断层扫描(CT)成像异常,42%(5/12)的PFT异常。不到一半的患者在诊断后6个月内接受了肺病科会诊。8名受试者(75%)在随后的观察期出现呼吸道表现。在有呼吸道症状的44个观察期中有23个(52%)进行了胸部CT或PFT检查,其中只有9个(20%)进行了肺部会诊。
这是美国第一项纵向描述儿童GPA患者呼吸道表现的研究,发现这些表现很常见且经常复发。我们的队列在诊断时几乎普遍存在影像学异常,无论有无呼吸道症状。在GPA患者的护理中早期与儿科肺病科合作,可能使风湿病团队能够有效评估复发症状并处理合并的肺部疾病。